secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2021-08-27T23:59:59+00:00
Accession:  0001193125-21-259349
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead Pharmaceuticals announces departure of Chief Commercial Officer James Hassard
--------------------------------------------------------------------------------

- James Hassard, former Chief Commercial Officer, left the company effective August 23, 2021.
- No replacement or interim appointment was disclosed in the filing.
- Company thanked Mr. Hassard for his service but provided no reason for departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000119312521259349/0001193125-21-259349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000119312521259349/d184220d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-259349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer